Table 2 Selection of patients for validation of the Glasgow alcoholic hepatitis score.

Hospital site	No. of patients: total (NT; CS)	Dates of recruitment	Inclusion/exclusion criteria	Indications for corticosteroids
Glasgow	38 (8; 30)	2002–3	GI bleeders excluded	CS used if sepsis excluded or adequately treated; mDF ⩾32
Birmingham	25 (19; 6)	2002–3	GI bleeders excluded	CS used if sepsis excluded or adequately treated; mDF ⩾32
Newcastle	65 (29; 36)	2000–3	Part of an RCT comparing antioxidants with placebo; mDF ⩾32	CS used if no active infection or GI bleeding
London	82 (38; 44)	1997–2001	RCT comparing antioxidants with CS; mDF ⩾32; serum bilirubin >100 μmol/l, serum creatinine <500 μmol/l. No active sepsis or GI bleeding for 48 hours	Randomised as part of RCT
Dudley	15 (14; 1)	2001–3	Patients with recent GI bleeding included	CS not used routinely

CS, Corticosteroids (40 mg prednisolone for 4 weeks except for London where 30 mg was given for 4 weeks); GI, gastrointestinal; mDF, modified Maddrey's discriminant factor; NT, not treated; RCT, randomised controlled trial; All patients had a serum bilirubin ⩾80 μmol/l, a history of recent alcohol excess and aspartate aminotransferase level <500 IU/l.